Replies to post #145335 on SMART MONEY GROUP

[TheFinalCD]

SPPI 5.50

[TheFinalCD]

all over the map on news https://ih.advfn.com/stock-market/NASDAQ/spectrum-pharmaceuticals-SPPI/stock-news/83965526/spectrum-provides-poziotinib-update-after-successf

$SPPI confusion, but Cohort 3 failed.

While Cohort 3 did not meet its pre-specified ORR endpoint, we are seeing evidence of clinical activity with a disease control rate (DCR) of 86% and progression free survival data of 7.2 months

Nice spin! But negative

— TexMex (@TraderTexMex) December 22, 2020